Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

153 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Principles and use of anti-CTLA4 antibody in human cancer immunotherapy.
Peggs KS, Quezada SA, Korman AJ, Allison JP. Peggs KS, et al. Curr Opin Immunol. 2006 Apr;18(2):206-13. doi: 10.1016/j.coi.2006.01.011. Epub 2006 Feb 7. Curr Opin Immunol. 2006. PMID: 16464564 Review.
The "Achilles' Heel" of Cancer and Its Implications for the Development of Novel Immunotherapeutic Strategies.
Joshi K, Chain BM, Peggs KS, Quezada SA. Joshi K, et al. Among authors: peggs ks. Cold Spring Harb Perspect Med. 2018 Jan 2;8(1):a027086. doi: 10.1101/cshperspect.a027086. Cold Spring Harb Perspect Med. 2018. PMID: 28630228 Free PMC article. Review.
Tumour heterogeneity and immune-modulation.
Jamal-Hanjani M, Thanopoulou E, Peggs KS, Quezada SA, Swanton C. Jamal-Hanjani M, et al. Among authors: peggs ks. Curr Opin Pharmacol. 2013 Aug;13(4):497-503. doi: 10.1016/j.coph.2013.04.006. Epub 2013 May 7. Curr Opin Pharmacol. 2013. PMID: 23664091 Free PMC article. Review.
Cell intrinsic mechanisms of T-cell inhibition and application to cancer therapy.
Peggs KS, Quezada SA, Allison JP. Peggs KS, et al. Immunol Rev. 2008 Aug;224:141-65. doi: 10.1111/j.1600-065X.2008.00649.x. Immunol Rev. 2008. PMID: 18759925 Review.
Checkpoint blockade in cancer immunotherapy.
Korman AJ, Peggs KS, Allison JP. Korman AJ, et al. Among authors: peggs ks. Adv Immunol. 2006;90:297-339. doi: 10.1016/S0065-2776(06)90008-X. Adv Immunol. 2006. PMID: 16730267 Free PMC article. Review.
CTLA4 blockade and GM-CSF combination immunotherapy alters the intratumor balance of effector and regulatory T cells.
Quezada SA, Peggs KS, Curran MA, Allison JP. Quezada SA, et al. Among authors: peggs ks. J Clin Invest. 2006 Jul;116(7):1935-45. doi: 10.1172/JCI27745. Epub 2006 Jun 15. J Clin Invest. 2006. PMID: 16778987 Free PMC article.
Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade.
McGranahan N, Furness AJ, Rosenthal R, Ramskov S, Lyngaa R, Saini SK, Jamal-Hanjani M, Wilson GA, Birkbak NJ, Hiley CT, Watkins TB, Shafi S, Murugaesu N, Mitter R, Akarca AU, Linares J, Marafioti T, Henry JY, Van Allen EM, Miao D, Schilling B, Schadendorf D, Garraway LA, Makarov V, Rizvi NA, Snyder A, Hellmann MD, Merghoub T, Wolchok JD, Shukla SA, Wu CJ, Peggs KS, Chan TA, Hadrup SR, Quezada SA, Swanton C. McGranahan N, et al. Among authors: peggs ks. Science. 2016 Mar 25;351(6280):1463-9. doi: 10.1126/science.aaf1490. Epub 2016 Mar 3. Science. 2016. PMID: 26940869 Free PMC article.
Shifting the equilibrium in cancer immunoediting: from tumor tolerance to eradication.
Quezada SA, Peggs KS, Simpson TR, Allison JP. Quezada SA, et al. Among authors: peggs ks. Immunol Rev. 2011 May;241(1):104-18. doi: 10.1111/j.1600-065X.2011.01007.x. Immunol Rev. 2011. PMID: 21488893 Free PMC article. Review.
Epitope landscape in breast and colorectal cancer.
Segal NH, Parsons DW, Peggs KS, Velculescu V, Kinzler KW, Vogelstein B, Allison JP. Segal NH, et al. Among authors: peggs ks. Cancer Res. 2008 Feb 1;68(3):889-92. doi: 10.1158/0008-5472.CAN-07-3095. Cancer Res. 2008. PMID: 18245491
Targeting immunosupportive cancer therapies: accentuate the positive, eliminate the negative.
Peggs KS, Segal NH, Allison JP. Peggs KS, et al. Cancer Cell. 2007 Sep;12(3):192-9. doi: 10.1016/j.ccr.2007.08.023. Cancer Cell. 2007. PMID: 17785201
153 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page